Novartis Wins Out In Patent Suit Over Hemophilia Drug
Novartis Vaccines and Diagnostics Inc. has prevailed in a patent dispute brought by Pfizer Inc. unit Genetics Institute LLC over the ownership of the formula for the hemophilia treatment ReFacto....To view the full article, register now.
Already a subscriber? Click here to view full article